Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties

Journal of Integrative Medicine

Volumn 16, Issue 3, 2018, Pages 147-152

  Chan, Eric Wei Chiang ^a   Wong, Siu Kuin ^b   Chan, Hung Tuck ^c  

^a UCSI UNIVERSITY   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Apoptosis; Molecular mechanisms; Polymethylflavone; Vitexicarpin

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CASTICIN; FLAVONE DERIVATIVE; HYDROXYL GROUP; UNCLASSIFIED DRUG; FLAVONOID; PLANT EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; DRUG STRUCTURE; HUMAN; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PLANT SEED; PRIORITY JOURNAL; REVIEW; VITEX; VITEX AGNUS CASTUS; VITEX NEGUNDO; VITEX TRIFOLIA; ANIMAL; CHEMISTRY; INFLAMMATION; NEOPLASM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FLAVONOIDS; HUMANS; INFLAMMATION; NEOPLASMS; PLANT EXTRACTS; VITEX;

EID: 85051800802     PISSN: 20954964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joim.2018.03.001     Document Type: Review

References (95)

1. Rasul, A., Zhao, B.J., Liu, J., Liu, B., Sun, J.X., Li, J., et al. Molecular mechanisms of casticin action: an update on its antitumor functions. Asian Pac J Cancer Prev 15 (2014), 9049–9058.
2. de Padua, L.S., Bunyapraphatsara, N., Lemmens, R.H.M.J., Plant resources of South-East Asia No. 12(1): medicinal and poisonous plants 1. 1999, Backhuys Publisher, Leiden, 497–502.
3. Ganapaty, S., Vidyadhar, K.N., Phytoconstituents and biological activities of Vitex—a review. J Nat Remed 5:2 (2005), 75–95.
4. eFloras.org. Vitex Linn. (1994). [2017-09-01]. http://flora.huh.harvard.edu/china/PDF/PDF17/vitex.pdf.
5. Meena, A.K., Singh, U., Yadav, A.K., Singh, B., Rao, M.M., Pharmacological and phytochemical evidences for the extracts from plants of the genus Vitex—a review. Int J Pharm Clin Res 2:1 (2010), 1–9.
6. Rani, A., Sharma, A., The genus Vitex: a review. Pharmacogn Rev 7:14 (2013), 188–198.
7. The Plant List 2013. Vitex. Version 1.1. [2017-11-20]. http://www.theplantlist.org/tpl1.1/search?q=vitex.
8. Chan, E.W.C., Baba, S., Chan, H.T., Kainuma, M., Tangah, J., Medicinal plants of sandy shores: a short review on Vitex trifolia L. and Ipomoea pes-caprae (L.). R Br Indian J Nat Prod Resour 7:2 (2016), 107–115.
9. Kondo, Y., Sugiyama, K., Nozoe, S., Studies on the constituents of Vitex rotundifolia L. Chem Pharm Bull (Tokyo) 34:11 (1986), 4829–4832.
10. Zeng, X., Fang, Z., Wu, Y., Zhang, H., Chemical constituents of the fruits of Vitex trifolia L. Zhongguo Zhong Yao Za Zhi 21:3 (1996), 167–168 [Chinese with abstract in English].
11. Yoshioka, T., Inokuchi, T., Fujioka, S., Kimura, Y., Phenolic compounds and flavonoids as plant growth regulators from fruit and leaf of Vitex rotundifolia. Z Naturforsch C 59 (2004), 509–514.
12. Chen, H.Y., Cheng, W.X., Feng, Y., Gu, K., Yang, L.J., Zhang, Y.P., Studies on flavonoid constituents of Vitex trifolia L. var. simplicifolia Cham. Tian Ran Chan Wu Yan Jiu Yu Kai Fa 20 (2008), 582–584 [Chinese].
13. Kim, H., Yi, J.M., Kim, N.S., Lee, Y.J., Kim, J., Oh, D.S., et al. Cytotoxic compounds from the fruits of Vitex rotundifolia against human cancer cell lines. J Korean Soc Appl Biol Chem 55 (2012), 433–437.
14. Meier, B., Berger, D., Hoberg, E., Sticher, O., Schaffner, W., Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 7:5 (2000), 373–381.
15. Chen, S.N., Friesen, J.B., Webster, D., Nikolic, D., van Breemen, R.B., Wang, Z.J., et al. Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia 82:4 (2011), 528–533.
16. Kikuchi, H., Yuan, B., Nishimura, Y., Imai, M., Furutani, R., Kamoi, S., et al. Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. Int J Oncol 43:6 (2013), 1976–1984.
17. Choudhary, M.I., Jalil, S., Nawaz, S.A., Khan, K.M., Tareen, R.B., Atta-ur-Rahman. Anti-inflammatory and lipoxygenase inhibitory compounds from Vitex agnus-castus. Phytother Res 23:9 (2009), 1336–1339.
18. Mesaik, M.A., Murad, S., Khan, K.M., Tareen, R.B., Ahmed, A., Choudhary, M.I., Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus. Phytother Res 23:11 (2009), 1516–1520.
19. Belič, I., Bergant-Dolar, J., Morton, R.A., Constituents of Vitex agnus-castus seeds. Part I. Casticin. J Chem Soc 73 (1961), 2523–2525.
20. Diaz, F., Chávez, D., Lee, D., Mi, Q., Chai, H.B., Tan, G.T., et al. Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo. J Nat Prod 66:6 (2003), 865–867.
21. Roy, S.K., Bairwa, K., Grover, J., Srivastava, A., Jachak, S.M., Analysis of flavonoids and iridoids in Vitex negundo by HPLC-PDA and method validation. Nat Prod Commun 8:9 (2013), 1241–1244.
22. Wang, Y., Hamburger, M., Gueho, J., Hostettmann, K., Antimicrobial flavonoids from Psiadia trinervia and their methylated and acetylated derivatives. Phytochemistry 28:9 (1989), 2323–2327.
23. Guerreiro, E., Pestchanker, M.J., Del Vitto, L., Giordano, O.S., Sesquiterpenes and flavonoids from Tessaria species. Phytochemistry 29:3 (1990), 877–879.
24. Zani, C.L., Alves, T., de Oliveira, A.B., Murta, S.M., Ceravolo, I.P., Romanha, A.J., Trypanocidal components of Pluchea quitoc L. Phytother Res 8:6 (1994), 375–377.
25. Kao, E.S., Wang, C.J., Lin, W.L., Yin, Y.F., Wang, C.P., et al. Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 53:2 (2005), 430–436.
26. Manosroi, A., Saraphanchotiwitthaya, A., Manosroi, J., In vivo immunomodulating activity of wood extracts from Clausena excavata Burm. f. J Ethnopharmacol 102:1 (2005), 5–9.
27. Haïdara, K., Zamir, L., Shi, Q.W., Batist, G., The flavonoid casticin has multiple mechanisms of tumour cytotoxicity action. Cancer Lett 242:2 (2006), 180–190.
28. Wu, Y., Wang, F., Zheng, Q., Lu, L., Yao, H., Zhou, C., et al. Hepatoprotective effect of total flavonoids from Laggera alata against carbon tetrachloride-induced injury in primary cultured neonatal rat hepatocytes and in rats with hepatic damage. J Biomed Sci 13:4 (2006), 569–578.
29. Spohr, T.C.L.S., Stipursky, J., Sasaki, A.C., Barbosa, P.R., Martins, V., Benjamim, C.F., et al. Effects of the flavonoid casticin from Brazilian Croton betulaster in cerebral cortical progenitors in vitro: direct and indirect action through astrocytes. J Neurosci Res 88:3 (2010), 530–541.
30. Xie, H., Liang, Y., Ito, Y., Wang, X., Chen, R., He, J., et al. Preparative isolation and purification of four flavonoids from Daphne genkwa Sieb. et Zucc. by high-speed counter-current chromatography. J Liq Chromatogr Relat Technol 34:19 (2011), 2360–2372.
31. Han, X., Ma, X.F., Zhang, T.Y., Zhang, Y.B., Liu, Q.H., Ito, Y., Isolation of high-purity casticin from Artemisia annua L. by high-speed counter-current chromatography. J Chromatogr A 1151:1–2 (2007), 180–182.
32. Marzouk, M.M., Mohamed, T.A., Elkhateeb, A., El-Toumy, S.A., Hegazy, M.E.F., Phenolics from Tanacetum sinaicum (Fresen.) Delile ex Bremer & Humphries (Asteraceae). Biochem Syst Ecol 65 (2016), 143–146.
33. Sun, W.Y., Li, J.F., Content determination of vitexicarpin in different organs of Vitex trifolia L. var. simplicifolia Cham. Yi Yao Dao Bao 31:2 (2012), 206–208 [Chinese].
34. Hoberg, E., Meier, B., Sticher, O., Quantitative high performance liquid chromatographic analysis of casticin in the fruits of Vitex agnus-castus. Pharm Biol 39:1 (2001), 57–61.
35. 2 fruit extracts compared with classical Soxhlet extracts. Planta Med, 76(12), 2010, P300.
36. Bae, H., Kim, Y., Lee, E., Park, S., Jung, K.H., Gu, M.J., et al. Vitex rotundifolia L. prevented airway eosinophilic inflammation and airway remodelling in an ovalbumin-induced asthma mouse model. Int Immunol 25:3 (2012), 197–205.
37. Ling, Y., Zhu, J., Fan, M., Wu, B., Qin, L., Huang, C., Metabolism studies of casticin in rats using HPLC-ESI-MS(n). Biomed Chromatogr 26:12 (2012), 1502–1508.
38. 2/M phase and induce apoptosis in mammalian cancer cells. J Asian Nat Prod Res 7:4 (2005), 615–626.
39. Wang, H.Y., Cai, B., Cui, C.B., Zhang, D.Y., Yang, B.F., Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway. Yao Xue Xue Bao 40:1 (2005), 27–31 [Chinese with abstract in English].
40. 2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from viticis fructus (Vitex rotundifolia Linn.). Cancer Lett 208:1 (2004), 59–64.
41. Xie, J., Bai, J., Sheng, X., Cao, J., Xie, W., Proliferation inhibition of human cervical cancer HeLa cells by casticin in vitro. Chinese-German J Clin Oncol 10:1 (2011), 47–50.
42. Shen, J.K., Du, H.P., Yang, M., Wang, Y.G., Jin, J., Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88:8 (2009), 743–752.
43. Song, Y.C., Zhang, X., Lei, G.Y., Dang, C.X., Vitexicarpin affects proliferation and apoptosis in mutated p53 breast cancer cell. Zhonghua Yi Xue Za Zhi 90:10 (2010), 703–707 [Chinese with abstract in English].
44. Yang, J., Yang, Y., Tian, L., Sheng, X.F., Liu, F., Cao, J.G., Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol 17:38 (2011), 4298–4307.
45. Zhou, Y., Tian, L., Long, L., Quan, M., Liu, F., Cao, J., Casticin potentiates trail-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. PLoS One, 8, 2013, e58855.
46. Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., Yano, M., Antiproliferative activity of flavonoids on several cancer lines. Biosci Biotechnol Biochem 63:5 (1999), 896–899.
47. Ko, W.G., Kang, T.H., Lee, S.J., Kim, N.Y., Kim, Y.C., Sohn, D.H., et al. Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation by inducing apoptosis in human myeloid leukemia cells. Food Chem Toxicol 38:10 (2000), 861–865.
48. Zeng, F., Tian, L., Liu, F., Cao, J., Quan, M., Sheng, X., Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai) 44:5 (2012), 442–449.
49. Liu, E., Kuang, Y., He, W., Xing, X., Gu, J., Casticin induces human glioma cell death through apoptosis and mitotic arrest. Cell Physiol Biochem 31:6 (2013), 805–814.
50. Song, Y.B., Zhou, S.H., Liu, H.N., Cui, H.S., Liu, L.J., Casticin treatment inhibits squamous cell carcinoma cell proliferation and arrests cell cycle in S phase. Bangladesh J Pharmacol 11 (2016), 206–211.
51. Ding, C., Khan, M., Zheng, B., Yang, J., Zhong, L., Ma, T., Casticin induces apoptosis and mitotic arrest in pancreatic carcinoma PANC-1 cells. Afr J Pharm Pharmacol 6:6 (2012), 412–418.
52. 2/M phase arrest. Asian Pac J Cancer Prev 13:12 (2012), 6369–6374.
53. Bai, J., Xie, W.Y., Tan, G.H., Cao, J.G., Effect of casticin on the growth of human ovarian carcinoma HO-8910 cells xenografts in nude mice. Zhongguo Xian Dai Yi Xue Za Zhi 21:4 (2011), 426–430 [Chinese].
54. Tang, S.Y., Zhong, M.Z., Yuan, G.J., Hou, S.P., Yin, L.L., Jiang, H., et al. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells. Oncol Rep 29:2 (2013), 474–480.
55. Yuan, S.Z., Zhuang, Y.Z., Cao, J.G., Effects of casticin on the growth and apoptosis of colon carcinoma cell line SW480. Zhongnan Yi Xue Ke Xue Za Zhi 39:2 (2011), 149–152 [Chinese with abstract in English].
56. Zhou, Y., Peng, Y., Mao, Q.Q., Li, X., Chen, M.W., Su, J., et al. Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells. Asian Pac J Trop Med 6:5 (2013), 372–378.
57. Qu, L., Liu, F.X., Cao, X.C., Xiao, Q., Yang, X., Ren, K.Q., Activation of the apoptosis signal–regulating kinase 1/c–Jun N–terminal kinase pathway is involved in the casticin–induced apoptosis of colon cancer cells. Exp Ther Med 8:5 (2014), 1494–1500.
58. Huang, L.P., Cao, X.C., Sheng, X.F., Zeng, B., Role of apoptosis signal-regulating kinase 1 activation in casticin-induced apoptosis of colon cancer cells. Hunan Shi Fan Da Xue Xue Bao (Yi Xue Ban) 9:3 (2012), 9–13 [Chinese].
59. He, L., Yang, X., Cao, X., Liu, F., Quan, M., Cao, J., Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma. Oncol Rep 29:1 (2013), 103–108.
60. Jiang, L., Cao, X.C., Cao, J.G., Liu, F., Quan, M.F., Sheng, X.F., et al. Casticin induces ovarian cancer cell apoptosis by repressing FoxM1 through the activation of FOXO3a. Oncol Lett 5:5 (2013), 1605–1610.
61. Liu, L.P., Ouyang, Q.C., Cao, J.G., Liu, F., Casticin induces breast cancer cell apoptosis by inhibition of FoxM1. Zhongguo Ai Zheng Za Zhi 22:12 (2012), 898–902 [Chinese].
62. Liu, L.P., Cao, X.C., Liu, F., Quan, M.F., Sheng, X.F., Ren, K.Q., Casticin induces breast cancer cell apoptosis by inhibiting the expression of fork-head box protein M1. Oncol Lett 7:5 (2014), 1711–1717.
63. He, M., Cao, X.C., He, G.C., Sheng, X.F., Ai, X.H., Wu, Y.H., Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through down-regulating Twist. Oncol Lett 7:5 (2014), 1625–1631.
64. Shiue, Y.W., Lu, C.C., Hsiao, Y.P., Liao, C.L., Lin, J.P., Lai, K.C., et al. Casticin induced apoptosis in A375.S2 human melanoma cells through the inhibition of NF-κB and mitochondria-dependent pathways in vitro and inhibited human melanoma xenografts in a mouse model in vivo. Am J Chin Med 44:3 (2016), 637–661.
65. Shih, Y.L., Chou, H.M., Chou, H.C., Lu, H.F., Chu, Y.L., Shang, H.S., et al. Casticin impairs cell migration and invasion of mouse melanoma B16F10 cells via PI3K/AKT and NF-κB signalling pathways. Environ Toxicol 32:9 (2017), 2097–2112.
66. Zhao, X., Cao, X.C., Yang, X.H., Quan, M.F., Chen, Z.D., Effects of casticin on the apoptosis and methylation of DAPK gene in cervical cancer HeLa cells. Zhong Liu Yao Xue 2:2 (2012), 106–109 [Chinese].
67. Wang, S.P., Yu, L., Xie, J., Liu, X.M., Li, H., Vitexicarpin inhibits overexpression of GNAO1 and plays a role in gastric cancer cell proliferation and apoptosis. Bangladesh J Pharmacol 10:1 (2015), 63–68.
68. Wang, C., Zhang, J., Wang, Z., Razzaq, M., Khan, M., Vitexicarpin induces apoptosis-independent mitotic arrest in U87 glioblastoma cells. Afr J Pharm Pharmacol 6:25 (2012), 1874–1882.
69. Shang, H.S., Liu, J.Y., Lu, H.F., Chiang, H.S., Lin, C.H., Chen, A., et al. Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells. Environ Toxicol 32:8 (2017), 2041–2052.
70. 1 cell cycle arrest in gallbladder cancer cells. Cancer Cell Int, 17, 2017, 9.
71. Chou, G.L., Peng, S.F., Liao, C.L., Ho, H.C., Lu, K.W., Lien, J.C., et al. Casticin impairs cell growth and induces cell apoptosis via cell cycle arrest in human oral cancer SCC-4 cells. Environ Toxicol 33:2 (2017), 127–141.
72. Yang, F., He, K., Huang, L., Zhang, L., Liu, A., Zhang, J., Casticin inhibits the activity of transcription factor Sp1 and the methylation of RECK in MGC803 gastric cancer cells. Exp Ther Med 13:2 (2017), 745–750.
73. You, K.M., Son, K.H., Chang, H.W., Kang, S.S., Kim, H.P., Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro. Planta Med 64:6 (1998), 546–550.
74. Lin, S., Zhang, H., Han, T., Wu, J.Z., Rahman, K., Qin, L.P., In vivo effect of casticin on acute inflammation. Zhong Xi Yi Jie He Xue Bao 5:5 (2007), 573–576 [Chinese with abstract in English].
75. Lee, S.M., Lee, Y.J., Kim, Y.C., Kim, J.S., Kang, D.G., Lee, H.S., Vascular protective role of vitexicarpin isolated from Vitex rotundifolia in human umbilical vein endothelial cells. Inflammation 35:2 (2012), 584–593.
76. Liou, C.J., Len, W.B., Wu, S.J., Lin, C.F., Wu, X.L., Huang, W.C., Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signalling in lipopolysaccharide-stimulated mouse macrophages. J Ethnopharmacol 158 (2014), 310–316.
77. Lee, C., Lee, J.W., Jin, Q., Lee, H.J., Lee, S.J., Lee, D., et al. Anti-inflammatory constituents from the fruits of Vitex rotundifolia. Bioorg Med Chem Lett 23:21 (2013), 6010–6014.
78. Lee, H., Jung, K.H., Lee, H., Park, S., Choi, W., Bae, H., Casticin, an active compound isolated from Vitex Fructus, ameliorates the cigarette smoke-induced acute lung inflammatory response in a murine model. Int Immunopharmacol 28:2 (2015), 1097–1101.
79. Koh, D.J., Ahn, H.S., Chung, H.S., Lee, H., Kim, Y., Lee, J.Y., et al. Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-κB inactivation. J Ethnopharmacol 136:3 (2011), 399–405.
80. Alam, G., Wahyuono, S., Ganjar, I.G., Hakim, K., Timmerman, H., Verpoorte, R., Tracheo-spasmolytic activity of viteosin-A and vitexicarpin isolated from Vitex trifolia. Planta Med 68:11 (2002), 1047–1049.
81. Hu, Y., Xin, H.L., Zhang, Q.Y., Zheng, H.C., Rahman, K., Qin, L.P., Antinociceptive and anti-hyperprolactinemia activities of Fructus Viticis and its effective fractions and chemical constituents. Phytomedicine 14:10 (2007), 668–674.
82. Ye, Q., Zhang, Q.Y., Zheng, C.J., Wang, Y., Qin, L.P., Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro. Acta Pharmacol Sin 31:12 (2010), 1564–1568.
83. Webster, D.E., He, Y., Chen, S.N., Pauli, G.F., Farnsworth, N.R., Wang, Z.J., Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. Biochem Pharmacol 81 (2011), 170–177.
84. Hu, Y., Hou, T.T., Zhang, Q.Y., Xin, H.L., Zheng, H.C., Qin, L.P., et al. Evaluation of the estrogenic activity of the constituents in the fruits of Vitex rotundifolia L. for the potential treatment of pre-menstrual syndrome. J Pharm Pharmacol 59:9 (2007), 1307–1312.
85. Zhang, B., Liu, L., Zhao, S., Wang, X., Liu, L., Li, S., Vitexicarpin acts as a novel angiogenesis inhibitor and its target network. Evid Based Complement Alternat Med, 2013, 2013, 278405.
86. Certo, G., Costa, R., D'Angelo, V., Russo, M., Albergamo, A., Dugo, G., et al. Anti-angiogenic activity and phytochemical screening of fruit fractions from Vitex agnus castus. Nat Prod Res 31:24 (2017), 2850–2856.
87. Feng, X., Zhou, Q., Liu, C., Tao, M.L., Drug screening study using glioma stem-like cells. Mol Med Rep 6:5 (2012), 1117–1120.
88. Wang, C., Zeng, L., Zhang, T., Liu, J., Wang, W., Casticin inhibits lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol 789 (2016), 172–178.
89. Li, Y., Shen, Y., Casticin attenuates rheumatoid arthritis through PKC-NF-κB signalling in vitro and in vivo. Int J Clin Exper Pathol 9:3 (2016), 2879–2887.
90. Zhou, L., Dong, X., Wang, L., Shan, L., Li, T., Xu, W., et al. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signalling pathway. Oncotarget 8 (2017), 56267–56280.
91. Berger, D., Schaffner, W., Schrader, E., Meier, B., Brattström, A., Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet 264:3 (2000), 150–153.
92. Schellenberg, R., Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 322 (2001), 134–137.
93. Schellenberg, R., Zimmermann, C., Drewe, J., Hoexter, G., Zahner, C., Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine 19:14 (2012), 1325–1331.
94. van Die, M.D., Burger, H.G., Teede, H.J., Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med 79:7 (2013), 562–575.
95. Daniele, C., Coon, J.T., Pittler, M.H., Ernst, E., Vitex agnus castus: a systematic review of adverse events. Drug Saf 28:4 (2005), 319–332.